Table 2.
Characteristic | 12-Month mGFR or Correlation Coefficient | P Value |
---|---|---|
Sex | <0.001 | |
Male | 59.6±16.9 | |
Female | 53.6±17.1 | |
Age at transplantation | r=−0.26 | <0.001 |
Donor type | <0.001 | |
Deceased donor | 55.1±17.3 | |
Living donor | 63.6±15.2 | |
Donor age | r=−0.48 | <0.001 |
Preemptive transplantation | 0.065 | |
Yes | 60.1±16.4 | |
No | 56.3±17.3 | |
Cold ischemia time (min) | <0.001 | |
≤250 | 63.4±15.2 | |
250–1200 | 57.9±16.9 | |
>1200 | 52.3±16.8 | |
Delayed graft function | 0.07 | |
Yes | 54.8±19.2 | |
No | 57.9±16.3 | |
Acute cellular rejection before 3 months | 0.46 | |
Yes | 53.6±13.1 | |
No | 60.0±21.7 | |
Acute humoral rejection before 3 months | 0.97 | |
Yes | 56.8±15.2 | |
No | 58.5±16.1 | |
3-month body mass index | r=0.09 | 0.046 |
3-month mGFR | r=0.78 | <0.001 |
3-month 25(OH)D | r=0.13 | 0.006 |
3-month PTH | ρ=0.07 | 0.15 |
3-month FGF-23 | ρ=0.30 | <0.001 |
3-month 1,25(OH)D | ρ=0.31 | <0.001 |
Values of 12-month mGFR are expressed in ml/min and reported as mean ± SD.
P values represent tests of significance from t test, Wilcoxon test, or Pearson or Spearman correlation tests, as appropriate.